Medicamentos exclusivos: aflibercept (Zaltrap), cabazitaxel (Jevtana) teriflunomida (Aubagio), plerixafor (Mozobil), agalsidasa beta (Fabrazyme), imiglucerasa (Cerezyme). Prórroga: PNSP 46/2019

Contract type	Supplies
CPV	33600000
Awarded to	Sanofi-Aventis, S. A.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.